Kenvue (NYSE: KVUE) is a publicly listed company headquartered in Summit, New Jersey, United States that owns 13 consumer brands across 2 categories, and has 1 recorded transaction.[1][2]
Kenvue is the consumer health business separated from Johnson & Johnson, listed in May 2023 and fully split off that August. It holds the self-care, skin health and essential health brands that Johnson & Johnson had built up over a century. Kimberly-Clark agreed to acquire Kenvue in November 2025.
What Kenvue's annual report says about its business
Read from Kenvue's latest annual filing[1]. Each line gives the sentence the filing uses, copied word for word.
Segments the filing names
Self Care: Our key competitors for each segment globally include: Self Care.
Skin Health and Beauty segment: For example, with respect to our Skin Health and Beauty segment, in July 2021, Johnson & Johnson Consumer Inc. ("Old JJCI") voluntarily recalled all lots of five Neutrogena and Aveeno aerosol sunscreen product lines to the consumer level and advised consumers to stop using the affected products out of an abundance of caution after 36 internal testing identified low levels of benzene in some samples of the products, though based on exposure modeling and the EPA's framework, daily exposure to benzene in the recalled products would not be expected to cause adverse health consequences.
Kenvue in numbers
Kenvue owns 13 consumer brands tracked here across 2 top-level categories; the largest is personal care & beauty with 7 brands.[1]
1 recorded acquisitions, 1 of them completed since 2015.
2 of its brands originated outside United States.
Kenvue financial history
Headline figures from Kenvue's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2022–2025.
Revenue moved from $15.1bn to $15.1bn, an average of 0.1% a year (calculated).
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Who owns the shares of Kenvue
Holders of more than 5% of the voting shares, as listed in Kenvue's proxy statement filed 8 April 2026. Shareholdings change daily; this is the position the filing reports.
Holder
Shares
Share of class
The Vanguard Group
233,245,730
12.15%
BlackRock, Inc.
129,017,456
6.72%
State Street Corporation
127,221,948
6.63%
Everything Kenvue owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
The Global Legal Entity Identifier Foundation (GLEIF) keeps an open register of legal entities. Each entity reports its own parents. We show it as a cross-check on the ownership recorded on this page, which is built from filings.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Official recalls involving Kenvue products
1 recall notice from government regulators matched to Kenvue.
Each applies to the specific products, sizes and lot codes named in the notice, not to every product sold under the name.
Matched automatically from FDA, USDA FSIS, UK Food Standards Agency and CPSC records only when the recalling firm corresponds to this ownership record and, for a brand, the brand name appears in the product description. Check the linked notice for exact products and lots. Method.
Frequently asked questions
What brands does Kenvue own?
⌄
Kenvue owns 13 consumer brands tracked here, including Listerine, Johnson's Baby, Neutrogena, Band-Aid, Aveeno and Benadryl.
Is Kenvue an American company?
⌄
Yes. Kenvue is headquartered in Summit, New Jersey, United States and was founded in 2023.
Who owns Kenvue?
⌄
Kenvue is a publicly listed company owned by its shareholders; it trades as KVUE on the NYSE.
What was Kenvue's most recent acquisition?
⌄
The most recent completed acquisition recorded here is Tylenol, Band-Aid, Listerine, Neutrogena, Aveeno, Johnson's Baby, Nicorette, Zyrtec, Motrin, Benadryl, OGX, Carefree and Stayfree on 23 August 2023.
Sources (3) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy